Positioning new pharmacotherapies for COPD

Por Barjaktarevic, Igor Z, Arredondo, Anthony F, Cooper, Christopher B
Publicado no Int J Chron Obstruct Pulmon Dis (2015)

The Role of Interleukin-23 in the Early Development of Emphysema in HIV1(+) Smokers

Por Barjaktarevic, Igor Z., Crystal, Ronald G., Kaner, Robert J.
Publicado no J Immunol Res (2016)

Reduced COPD Exacerbation Risk Correlates With Improved FEV(1): A Meta-Regression Analysis

Por Zider, Alexander D., Wang, Xiaoyan, Buhr, Russell G., Sirichana, Worawan, Barjaktarevic, Igor Z., Cooper, Christopher B.
Publicado no Chest (2017)

An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup

Por Christenson, Stephanie A., van den Berge, Maarten, Faiz, Alen, Inkamp, Kai, Bhakta, Nirav, Bonser, Luke R., Zlock, Lorna T., Barjaktarevic, Igor Z., Barr, R. Graham, Bleecker, Eugene R., Boucher, Richard C., Bowler, Russell P., Comellas, Alejandro P., Curtis, Jeffrey L., Han, MeiLan K., Hansel, Nadia N., Hiemstra, Pieter S., Kaner, Robert J., Krishnanm, Jerry A., Martinez, Fernando J., O’Neal, Wanda K., Paine, Robert, Timens, Wim, Wells, J. Michael, Spira, Avrum, Erle, David J., Woodruff, Prescott G.
Publicado no J Clin Invest (2018)